The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The findings, from the SPACE study, paved the way for FDA approval of AJOVY for pediatric patients aged 6-17 years weighing 45 kilograms
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
Subscribe To Our Newsletter & Stay Updated
